These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32558231)

  • 1. Dermatofibrosarcoma protuberans in children and adolescents: The European Paediatric Soft Tissue Sarcoma Study Group prospective trial (EpSSG NRSTS 2005).
    Brennan B; Zanetti I; De Salvo GL; Orbach D; Gallego S; Francotte N; Schifflers S; Van Noesel M; Kelsey A; Casanova M; Dagrada GP; Collini P; Zin A; Santoro L; Ferrari A
    Pediatr Blood Cancer; 2020 Oct; 67(10):e28351. PubMed ID: 32558231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alveolar soft part sarcoma in children and adolescents: The European Paediatric Soft Tissue Sarcoma study group prospective trial (EpSSG NRSTS 2005).
    Brennan B; Zanetti I; Orbach D; Gallego S; Francotte N; Van Noesel M; Kelsey A; Casanova M; De Salvo GL; Bisogno G; Ferrari A
    Pediatr Blood Cancer; 2018 Apr; 65(4):. PubMed ID: 29286582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paediatric non-rhabdomyosarcoma soft tissue sarcomas: the prospective NRSTS 2005 study by the European Pediatric Soft Tissue Sarcoma Study Group (EpSSG).
    Ferrari A; van Noesel MM; Brennan B; Zanetti I; Corradini N; Casanova M; Berlanga P; Merks JHM; Alaggio R; Schifflers S; Ramirez-Villar GL; Giraudo C; Burrieza GG; Safwat A; Bisogno G; De Salvo GL; Orbach D
    Lancet Child Adolesc Health; 2021 Aug; 5(8):546-558. PubMed ID: 34214481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adolescents and young adults with rhabdomyosarcoma treated in the European paediatric Soft tissue sarcoma Study Group (EpSSG) protocols: a cohort study.
    Ferrari A; Chisholm JC; Jenney M; Minard-Colin V; Orbach D; Casanova M; Guillen G; Glosli H; van Rijn RR; Schoot RA; Cameron AL; Rogers T; Alaggio R; Ben-Arush M; Mandeville HC; Devalck C; Defachelles AS; Coppadoro B; Bisogno G; Merks JHM
    Lancet Child Adolesc Health; 2022 Aug; 6(8):545-554. PubMed ID: 35690071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcomas: Standard of Care and Treatment Recommendations from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).
    Ferrari A; Brennan B; Casanova M; Corradini N; Berlanga P; Schoot RA; Ramirez-Villar GL; Safwat A; Guillen Burrieza G; Dall'Igna P; Alaggio R; Lyngsie Hjalgrim L; Gatz SA; Orbach D; van Noesel MM
    Cancer Manag Res; 2022; 14():2885-2902. PubMed ID: 36176694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of extracranial malignant rhabdoid tumours in children registered in the European Paediatric Soft Tissue Sarcoma Study Group Non-Rhabdomyosarcoma Soft Tissue Sarcoma 2005 Study-EpSSG NRSTS 2005.
    Brennan B; De Salvo GL; Orbach D; De Paoli A; Kelsey A; Mudry P; Francotte N; Van Noesel M; Bisogno G; Casanova M; Ferrari A
    Eur J Cancer; 2016 Jun; 60():69-82. PubMed ID: 27082136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single-institutional review of 68 patients with dermatofibrosarcoma protuberans: wide re-excision after inadequate previous surgery results in a high rate of local control.
    Harati K; Lange K; Goertz O; Lahmer A; Kapalschinski N; Stricker I; Lehnhardt M; Daigeler A
    World J Surg Oncol; 2017 Jan; 15(1):5. PubMed ID: 28056985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome after surgical treatment of dermatofibrosarcoma protuberans: Is clinical follow-up always indicated?
    Huis In 't Veld EA; van Coevorden F; Grünhagen DJ; Smith MJ; van Akkooi ACJ; Wouters MWJM; Hayes AJ; Verhoef C; Strauss DC; van Houdt WJ
    Cancer; 2019 Mar; 125(5):735-741. PubMed ID: 30644528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital dermatofibrosarcoma protuberans: 30 years of follow-up.
    von Stebut E; Brsuninger W
    J Dtsch Dermatol Ges; 2007 Mar; 5(3):223-5. PubMed ID: 17338798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermatofibrosarcoma protuberans: our 10-year experience on 80 patients.
    Zhou X; Sun D; Liu Y; Sun Q; Yuan Z; Luo X; Yang J; Chen J
    J Dermatolog Treat; 2020 Sep; 31(6):554-558. PubMed ID: 31116621
    [No Abstract]   [Full Text] [Related]  

  • 11. Outcome After Surgical Treatment of Dermatofibrosarcoma Protuberans (DFSP): Does it Require Extensive Follow-up and What is an Adequate Resection Margin?
    Alshaygy I; Mattei JC; Basile G; Griffin AM; Gladdy RA; Swallow CJ; Dickson BC; Wunder JS; Ferguson PC
    Ann Surg Oncol; 2023 May; 30(5):3106-3113. PubMed ID: 36658251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermatofibrosarcoma protuberans: A clinicopathologic analysis of patients treated and followed at a single institution.
    Bowne WB; Antonescu CR; Leung DH; Katz SC; Hawkins WG; Woodruff JM; Brennan MF; Lewis JJ
    Cancer; 2000 Jun; 88(12):2711-20. PubMed ID: 10870053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans. Results of a multiinstitutional series with an analysis of the extent of microscopic spread.
    Ratner D; Thomas CO; Johnson TM; Sondak VK; Hamilton TA; Nelson BR; Swanson NA; Garcia C; Clark RE; Grande DJ
    J Am Acad Dermatol; 1997 Oct; 37(4):600-13. PubMed ID: 9344201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermatofibrosarcoma Protuberans: Wide Local Excision Versus Mohs Micrographic Surgery.
    Mullen JT
    Surg Oncol Clin N Am; 2016 Oct; 25(4):827-39. PubMed ID: 27591501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conservative Re-excision is a Safe and Simple Alternative to Radical Resection in Revision Surgery for Dermatofibrosarcoma Protuberans.
    Snow H; Davies E; Strauss DC; Smith M; Hayes AJ
    Ann Surg Oncol; 2020 Mar; 27(3):919-923. PubMed ID: 31664620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution.
    DuBay D; Cimmino V; Lowe L; Johnson TM; Sondak VK
    Cancer; 2004 Mar; 100(5):1008-16. PubMed ID: 14983497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison between Mohs micrographic surgery and wide surgical excision for the treatment of dermatofibrosarcoma protuberans.
    Gloster HM; Harris KR; Roenigk RK
    J Am Acad Dermatol; 1996 Jul; 35(1):82-7. PubMed ID: 8682970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermatofibrosarcoma protuberans: a population-based cancer registry descriptive study of 66 consecutive cases diagnosed between 1982 and 2002.
    Monnier D; Vidal C; Martin L; Danzon A; Pelletier F; Puzenat E; Algros MP; Blanc D; Laurent R; Humbert PH; Aubin F
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1237-42. PubMed ID: 17062038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of surgical treatment for dermatofibrosarcoma protuberans according to width of gross resection margin.
    Woo KJ; Bang SI; Mun GH; Oh KS; Pyon JK; Lim SY
    J Plast Reconstr Aesthet Surg; 2016 Mar; 69(3):395-401. PubMed ID: 26646402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracranial infiltration by recurrent scalp dermatofibrosarcoma protuberans.
    Abe T; Kamida T; Goda M; Inoue R; Fujiki M; Kobayashi H; Hatano Y; Shibuya H; Fujiwara S; Terashi H; Mori T
    J Clin Neurosci; 2009 Oct; 16(10):1358-60. PubMed ID: 19560926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.